IQVIA Releases: Review of China's Retail Pharmacy Market in 2021

China Retail Pharmacy Market Overview

In 2021, the market size of retail pharmacies in China's prefecture-level cities and municipal districts* will reach 204.

* Market size: retail pharmacy point-of-sale amount

** MAT (rolling full year data): The sum of the data going back 12 months at the specified time node, here refers to the sales from the first quarter of 2021 to the fourth quarter of 2021

Detailed explanation of the retail pharmacy market

1.

The concentration of the retail over-the-counter drug and health care products market is further strengthened, with the top 20 groups occupying 35.

2.

Among the sales categories in the retail over-the-counter medicines and health care products market, cold and cough medicines are the largest category, accounting for 24.

Judging from the product ranking, it is consistent with the overall market and category performance:

• Among the top 20 OTC drugs and health care products (Figure 3), 11 are Chinese patent medicines, and 9 are Western medicines and health care products

• Only 3 products are from multinational companies, accounting for 2.

• In terms of sales, the Ejiao products produced by Dong'e Ejiao ranked first, but the growth rate was negative

• The Tiepi Fengdou Granules of Zhejiang Emperor Pharmaceutical had the highest MAT growth rate of 20.

2) Prescription drugs

In the retail prescription drug market, Chinese patent medicine is still the largest category, accounting for 23.

• Among the top 20 groups, multinational companies and local companies are evenly divided, and AstraZeneca ranks first

• Among the top 20 prescription drug products, 12 are multinational products, accounting for 10.

• Viagra, Lipitor and Norvox won the top three sales of prescription drugs respectively
.
Novartis' antihypertensive drugs, Bebote and Diovan, "returned" to the top 20, showing good market activity
.
Drugs for chronic diseases such as blood lipid regulators, antithrombotics, and hypertension drugs occupy many seats on the list
.

List of 41 cities*:

First line: Beijing, Shanghai, Guangzhou, Shenzhen

Second line: Changsha, Chengdu, Chongqing, Dalian, Dongguan, Fuzhou, Harbin, Hangzhou, Jinan, Nanjing, Ningbo, Qingdao, Shenyang, Tianjin, Wuhan, Xi'an, Zhengzhou City

Third line: Changzhou City, Foshan City, Guiyang City, Hefei City, Hohhot City, Huizhou City, Kunming City, Linyi City, Nanchang City, Nanning City, Shijiazhuang City, Taiyuan City, Taizhou City, Weifang City, Wenzhou City, Wuxi City, Xuzhou and Yantai

Fourth line: Huaian City, Yichang City

Data source: "IQVIA National Statistics Report on Retail Pharmacies in Prefectural-level Cities and Municipal Districts"

Note: IQVIA PharmaTrend™ has undergone a database update in March 2022, and historical data has been adjusted accordingly
.